Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab

Figure 1

HR-CT findings on day 1 with few focal ground-glass opacifications (GGO), day 9 with GGO dissemination, and day 16 with substantial improvement of the lung parenchyma.